GlobeNewswire Inc.··Proqr Therapeutics N.V.ProQR Adds Pharma Veteran Dr. Lykke Hinsch Gylvin to Board
ProQR Therapeutics nominates Boehringer Ingelheim's Chief Medical Officer Dr. Lykke Hinsch Gylvin to its Board, pending shareholder approval.
PRQRclinical developmentdrug development